|
Volumn 13, Issue 9 SUPPL. D, 2007, Pages
|
Chronic kidney disease and medicare
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERGOCALCIFEROL;
INSULIN;
IRON;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RECOMBINANT ERYTHROPOIETIN;
VITAMIN D;
ANEMIA;
ARTICLE;
CARDIOVASCULAR DISEASE;
CHRONIC KIDNEY DISEASE;
COMORBIDITY;
COST MINIMIZATION ANALYSIS;
COST OF ILLNESS;
DIABETES MELLITUS;
DRUG COST;
GRAFT REJECTION;
HEALTH CARE ACCESS;
HEALTH CARE QUALITY;
HEALTH PROGRAM;
HUMAN;
HYPERTENSION;
KIDNEY FAILURE;
KIDNEY GRAFT;
MANAGED CARE;
MEDICAID;
MEDICARE;
PHARMACY;
PRESCRIPTION;
RENAL OSTEODYSTROPHY;
RENAL REPLACEMENT THERAPY;
HUMANS;
KIDNEY FAILURE, CHRONIC;
MANAGED CARE PROGRAMS;
MEDICARE PART D;
UNITED STATES;
|
EID: 38649083432
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (12)
|